These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1199 related items for PubMed ID: 18379200

  • 21. Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children.
    Pajaron-Fernandez M, Garcia-Rubia S, Sanchez-Solis M, Garcia-Marcos L.
    Pediatr Pulmonol; 2006 Mar; 41(3):222-7. PubMed ID: 16429427
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
    Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G.
    J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
    Moeller A, Lehmann A, Knauer N, Albisetti M, Rochat M, Johannes W.
    Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
    [Abstract] [Full Text] [Related]

  • 29. Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
    Anderson SD, Brannan JD, Perry CP, Caillaud C, Seale JP.
    J Asthma; 2010 May; 47(4):429-33. PubMed ID: 20528598
    [Abstract] [Full Text] [Related]

  • 30. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I, Reiss TF, Rochette F, Botto A, Zhang J, Kundu S, Decramer M.
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [Abstract] [Full Text] [Related]

  • 31. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
    Becker A, Swern A, Tozzi CA, Yu Q, Reiss T, Knorr B.
    Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M, Imbe S, Sato R, Ikeda Y, Yamagata S, Iwanaga T, Tohda Y.
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [Abstract] [Full Text] [Related]

  • 35. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
    Rabinovitch N, Strand M, Stuhlman K, Gelfand EW.
    J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. TBXA2R gene polymorphism and responsiveness to leukotriene receptor antagonist in children with asthma.
    Kim JH, Lee SY, Kim HB, Jin HS, Yu JH, Kim BJ, Kim BS, Kang MJ, Jang SO, Hong SJ.
    Clin Exp Allergy; 2008 Jan; 38(1):51-9. PubMed ID: 18031559
    [Abstract] [Full Text] [Related]

  • 40. Exercise-induced wheeze: Fraction of exhaled nitric oxide-directed management.
    Cowan DC, Hewitt RS, Cowan JO, Palmay R, Williamson A, Lucas SJ, Murrell CJ, Thomas KN, Taylor DR.
    Respirology; 2010 May; 15(4):683-90. PubMed ID: 20337988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.